Abiopharma

Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes

Wells Fargo Investment Institute: When Every Headline Shouts, Discipline Matters Most

Ernexa Therapeutics Positioned to Become a Clinical-Stage Biotechnology Company as ERNA-101 On Track for Planned Q3 2026 IND Submission and First-in-Human Study

Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026

Duos Technologies Group Closes $55M Registered Direct Offering

Mountain Crest Acquisition 6 Corp. Announces the Separate Trading of its Ordinary Shares and Rights, Commencing on June 22, 2026

NUBURU Presents NUBURU Defense Italian Plan and Strengthens Strategic Team Following Golden Power Notification

Businesses overestimate real progress on AI

MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum

Federated Hermes launches active ETF offering investors access to leading international companies